An MRI before treatment in men undergoing radical prostatectomy can provide independent prognostic value for oncologic ...

The investment into Lucida Medical is an investment into patented AI software designed to support earlier and more consistent ...

Precision Prostate Consulting, LLC announces its rebrand to DeepView Imaging, reflecting the company's mission to provide patients with direct, on-demand access to AI-powered prostate MRI analysis.

Lucida Medical has raised £8.7m to power its ‘same-day’ cancer diagnosis. IW Capital has invested in the Cambridge healthtech ...

IW Capital has invested in Lucida Medical, a Cambridge and UK healthtech company using AI to help clinicians diagnose prostate cancer from MRI scans faster and more accurately.

For its 2nd anniversary, Callisto DataHub offers free annotated datasets of 50 suspected lung cancer X-rays and 50 ...

A newly established AI-assisted MRI centre has opened up 18,000 annual slots to meet rising demand across Singapore.

The whole-body MRI machines whir, in conversation with the skeleton staring back at me on the computer screen. On a gray ...

HKSH Medical Group (HKSH) today announced the results of Asia's first clinical study on early-stage prostate cancer patients receiving five-session of proton therapy.* The results show significant ...

Primary endpoint analysis at 1 year showed better maintenance of erectile function and pad-free continence with TULSA than with robotic radical prostatectomy. Peri-procedural metrics favored TULSA, ...

A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...